Stifel Financial
SBBP

Stifel Financial’s Strongbridge Biopharma plc. SBBP Stock Holding History

Stifel Financial’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,800
Closed -$53K – 3019
2019
Q2 		$53K Buy
16,800
+1,200
+8% +$4.41K ﹤0.01% 2858
2019
Q1 		$76K Sell
15,600
-1,525
-9% -$7.51K ﹤0.01% 2716
2018
Q4 		$73K Buy
+17,125
New +$83.6K ﹤0.01% 2586
2018
Q2 		– Sell
-10,884
Closed -$96K – 2810
2018
Q1 		$96K Buy
+10,884
New +$81.5K ﹤0.01% 2575

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Financial's SBBP Position: Q3 2019 in Review

Stifel Financial sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2019, closing a stake of 16,800 shares — an estimated $53K sold.

Stifel Financial first reported a position in SBBP in Q1 2018 and held it in 4 quarters. The position peaked at $96K in Q1 2018. 54 funds tracked by Wall St. Rank hold SBBP as of Q3 2019.

  • Stifel Financial reported no remaining Strongbridge Biopharma plc. position as of Q3 2019 after selling out during the quarter.
  • Stifel Financial sold 16,800 Strongbridge Biopharma plc. shares in Q3 2019, an estimated $53K.
  • Stifel Financial first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 4 quarters.
  • Stifel Financial's Strongbridge Biopharma plc. position peaked at $96K in Q1 2018.
  • 54 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2019.

Based on Stifel Financial's 13F filing for Q3 2019, filed 13 Nov 2019.